Argenx
ARGX
#504
Rank
NZ$82.91 B
Marketcap
NZ$1,327
Share price
-0.98%
Change (1 day)
32.30%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company